Literature DB >> 11797173

Disseminated phaeohyphomycosis: review of an emerging mycosis.

Sanjay G Revankar1, Jan E Patterson, Deanna A Sutton, Renee Pullen, Michael G Rinaldi.   

Abstract

Disseminated phaeohyphomycosis is an uncommon infection caused by dematiaceous fungi, although the number of case reports about this infection has been increasing in recent years. A total of 72 cases are reviewed. Scedosporium prolificans is by far the most common cause. The presence of melanin in their cell walls may be a virulence factor for these fungi. The primary risk factor is decreased host immunity, although cases in apparently immunocompetent patients have been reported. Eosinophilia was seen in 11% of cases. Endocarditis is mostly reported on bioprosthetic valves, particularly those of porcine origin. The outcome of antifungal therapy remains poor, with an overall mortality rate of 79%. Special precautions taken for immunocompromised patients may help prevent exposure to fungi during the patients' period of greatest risk. The development of newer antifungal agents and combination therapy may hold promise in improving the management of these devastating infections in the future.

Entities:  

Mesh:

Year:  2002        PMID: 11797173     DOI: 10.1086/338636

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  72 in total

1.  Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.

Authors:  B P Howden; M A Slavin; A P Schwarer; A M Mijch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-14       Impact factor: 3.267

2.  Disseminated Cladophialophora bantiana disease in a patient with prediabetes.

Authors:  Anas Mansour; Kim Jordan
Journal:  BMJ Case Rep       Date:  2014-11-14

3.  Sixty-year-old man with slowly expanding nodular plaque on the thigh.

Authors:  Peggy A Wu; Maria L Turner; Edward W Cowen; Eleanor Wilson; Yvonne R Shea; Timothy Jancel; Alexandra F Freeman
Journal:  J Am Acad Dermatol       Date:  2010-12       Impact factor: 11.527

4.  Treatment options in emerging mold infections.

Authors:  Patricia Muñoz; Jesús Guinea; Emilio Bouza
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

5.  Detection of antibodies against Paracoccidioides brasiliensis melanin in in vitro and in vivo studies during infection.

Authors:  Martha E Urán; Joshua D Nosanchuk; Angela Restrepo; Andrew J Hamilton; Beatriz L Gómez; Luz E Cano
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

6.  Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy.

Authors:  Yotaro Ochi; Nobuhiro Hiramoto; Hiroshi Takegawa; Noboru Yonetani; Asako Doi; Chihiro Ichikawa; Yukihiro Imai; Takayuki Ishikawa
Journal:  Int J Hematol       Date:  2015-01-29       Impact factor: 2.490

7.  Fungal meningoencephalitis caused by Alternaria: a clinical case.

Authors:  Cícero J C Silveira; Joana Amaral; Rodrigo P Gorayeb; José Cabral; Teresa Pacheco
Journal:  Clin Drug Investig       Date:  2013-02       Impact factor: 2.859

8.  Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.

Authors:  M Simitsopoulou; C Gil-Lamaignere; N Avramidis; A Maloukou; S Lekkas; E Havlova; L Kourounaki; D Loebenberg; E Roilides
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 9.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

10.  Infection with Scedosporium apiospermum and S. prolificans, Australia.

Authors:  Louise Cooley; Denis Spelman; Karin Thursky; Monica Slavin
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.